SAN DIEGO--(BUSINESS WIRE)--Feb. 6, 2006--AVANIR Pharmaceuticals (AMEX:AVN.R) reported on the results of its 2006 Annual Meeting of Shareholders held today. Eric K. Brandt, AVANIR’s President and Chief Executive Officer, Charles A. Mathews, Chairman of the Board at AVANIR Pharmaceuticals, and Jonathan T. Silverstein, General Partner at OrbiMed Advisors LLC, were all re-elected to the Board as Class II Directors to serve a three-year term. In addition to the three Directors elected at this meeting, the Directors continuing in office are Stephen G. Austin, David J. Mazzo, Ph.D., Dennis G. Podlesak, Paul G. Thomas, Craig A. Wheeler and Scott M. Whitcup, Ph.D. All of the directors, with the exception of Eric Brandt, are independent outside directors.
